Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

Kebilidi is the first approved gene therapy that can be directly administered to the brain. Its OK secures a priority review ...

Lähteenvuo notes that while more research is called for, drugs like Ozempic may offer hope to those burdened by addiction, ...